Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Vos

Showing results (131-140 of 297) with videos related to

Pageof 30
Sort By:
Transplantation|February 17, 2017
Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center ExperienceDavid Ruttens, An Martens, Sofie Ordies, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 2, 2023
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 YearsVibeke K J Vergote, Christophe M Deroose, Steffen Fieuws, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 4, 2015
Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantationJana Somers, David Ruttens, Stijn E Verleden, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 8, 2024
COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center AnalysisSaartje Demolder, Veronique Schaevers, Katrien Lagrou, et al.
Clinical Transplantation|January 21, 2020
Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center studyStijn E Verleden, Jan Von Der Thüsen, Anke Van Herck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2009
Obliterative bronchiolitis following lung transplantation: from old to new concepts?Geert M Verleden, Robin Vos, Stéphanie I De Vleeschauwer, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 26, 2008
Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injuryNele Geudens, Lien Timmermans, Hadewijch Vanhooren, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2025
Correction to: Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safetyBart Forier, Veronique Schaevers, Isabel Spriet, et al.
The European Respiratory Journal|August 24, 2019
Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunctionAnnelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, et al.
Pageof 30

Showing results (131-140 of 297) with videos related to

Sort By:
Pageof 30
Transplantation|February 17, 2017
Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center ExperienceDavid Ruttens, An Martens, Sofie Ordies, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 2, 2023
Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 YearsVibeke K J Vergote, Christophe M Deroose, Steffen Fieuws, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 4, 2015
Interleukin-17 receptor polymorphism predisposes to primary graft dysfunction after lung transplantationJana Somers, David Ruttens, Stijn E Verleden, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 8, 2024
COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center AnalysisSaartje Demolder, Veronique Schaevers, Katrien Lagrou, et al.
Clinical Transplantation|January 21, 2020
Identification and characterization of chronic lung allograft dysfunction patients with mixed phenotype: A single-center studyStijn E Verleden, Jan Von Der Thüsen, Anke Van Herck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 4, 2009
Obliterative bronchiolitis following lung transplantation: from old to new concepts?Geert M Verleden, Robin Vos, Stéphanie I De Vleeschauwer, et al.
Mycoses|May 8, 2021
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokineticsRuth Van Daele, Yves Debaveye, Robin Vos, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 26, 2008
Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injuryNele Geudens, Lien Timmermans, Hadewijch Vanhooren, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 14, 2025
Correction to: Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safetyBart Forier, Veronique Schaevers, Isabel Spriet, et al.
The European Respiratory Journal|August 24, 2019
Intragraft donor-specific anti-HLA antibodies in phenotypes of chronic lung allograft dysfunctionAnnelore Sacreas, Jean-Luc Taupin, Marie-Paule Emonds, et al.
Pageof 30